Undervalued over 20% based on DCF

Results

5058

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

5058 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MSFT
US$418.57-1.2%-7.0%US$3.1tUS$560.6324.813.4%0.9%Software
AMZN
US$266.320.6%32.5%US$2.9tUS$312.6331.616.2%n/aRetail
BRK.A
US$728,641.00-0.2%-3.4%US$1.0tUS$758,899.0014.5-2.4%n/aDiversified Financials
LLY
US$1,065.007.8%49.2%US$949.7bUS$1,211.0337.616.7%0.6%Pharmaceuticals & Biotech
JPM
US$306.381.9%17.5%US$820.9bUS$342.192.43.9%2.0%Banks
XOM
US$154.92-3.5%50.4%US$642.1bUS$168.3225.49.5%2.7%Energy
JNJ
US$234.342.4%53.2%US$564.1bUS$252.9626.88.3%2.3%Pharmaceuticals & Biotech
ORCL
US$192.082.9%23.2%US$552.4bUS$244.0334.125.4%1.0%Software
ABBV
US$215.703.0%17.7%US$381.1bUS$252.90106.025.2%3.2%Pharmaceuticals & Biotech
BAC
US$51.802.2%19.9%US$367.6bUS$63.161.36.1%2.2%Banks
PG
US$144.441.4%-12.9%US$336.3bUS$163.7720.63.8%3.0%Household
HSBA
UK£13.742.7%58.2%UK£235.7bUK£14.021.610.8%4.1%Banks
MRK
US$122.418.8%57.8%US$302.3bUS$129.7433.821.2%2.8%Pharmaceuticals & Biotech
AZN
UK£139.161.5%33.3%UK£215.8bUK£164.9127.913.5%1.7%Pharmaceuticals & Biotech
300750
CN¥402.88-3.4%57.4%CN¥1.9tCN¥546.1123.416.2%2.0%Capital Goods
RY
CA$264.154.6%49.8%CA$365.9bCA$252.392.94.2%2.5%Banks
NESN
CHF 78.780.7%-11.1%CHF 202.6bCHF 87.8722.48.2%3.9%Food, Beverage & Tobacco
941
HK$85.50-1.5%-3.7%HK$1.9tHK$96.7611.83.0%6.2%Telecom
IBM
US$253.8414.0%-1.9%US$238.6bUS$277.6822.25.8%2.7%Software
WFC
US$76.402.7%4.9%US$233.8bUS$96.111.44.5%2.4%Banks
8306
JP¥3,066.002.4%56.8%JP¥34.6tJP¥3,130.001.65.8%3.1%Banks
C
US$125.092.2%71.1%US$213.4bUS$146.931.19.7%1.9%Banks
AXP
US$311.78-0.1%9.3%US$212.7bUS$361.5719.28.7%1.2%Diversified Financials
SAP
€154.484.5%-41.1%€180.4b€214.8124.714.9%1.6%Software
Page 1 of 141